UPPSALA, Sweden, July 5, 2024 /PRNewswire/ -- The biotech tools company MAGic™ BioProcessing, announces that both USA and China have granted patent rights to the patent of combinatory separation system for the MAGic™ Accio, the seamlessly scalable magnetic separator.

The patent underscores MAGic™ BioProcessing's dedication to push the boundaries of innovation in the field of separation technology and solidifies our cutting-edge biotechnological solutions resulting in:

Simplified separation process and reduction of process steps
Reduced costs
Streamlines workflows
Optimized efficiency and utility, due to a single step process

MAGic™ BioProcessing remains committed to advancing the field of separation technology and delivering innovative solutions that address the evolving needs of bio manufacturing. With this patented technology, MAGic™ BioProcessing is poised to revolutionize separation processes, driving efficiency, and enabling new processes in biotechnology and beyond.

For more information, please contact:
Peter Karlberg, CEO
Tel:+46 76-3290814
peter@magicbioprocessing.com

or visit our webpage https://magicbioprocessing.com

About MAGic™ BioProcessing:

MAGic™ BioProcessing is a biotech tools company from Uppsala, Sweden that develops and sells proprietary magnetic-based products and methods for bioprocessing of biologics such as recombinant proteins, monoclonal antibodies, viral vectors, and cells.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/magic-bioprocessing/r/magic--bioprocessing-secures-patent-in-usa-and-china,c4010832

The following files are available for download:


     
     https://news.cision.com/magic-bioprocessing/i/bead-with-antibodies-01,c3317523 bead with antibodies
                                                                                        01

View original content:https://www.prnewswire.co.uk/news-releases/magic-bioprocessing-secures-patent-in-usa-and-china-302189974.html

Tags

More Like This

MAGic™ BioProcessing welcomes a new team member

MAGic™ BioProcessing Announces Changes to Board of Directors

Zymo Research Stands by Its Innovative cfDNA Technology in Response to Qiagen's Lawsuit

BioProcess360 Partners Launches New Chromatography Company Through Transfer of IP, Assets and Personnel from LigaTrap Technologies

Zymo Research Responds to Recent Court Ruling in Litigation with QIAGEN GmbH

NAYO to Announce the Launch of Fully Automated Biobanking Solutions in Europe at Medica 2024

Stämm's Continuous Bioreactor Increases Antibody Productivity by up to 30x in European and American Pilots

EMA Approves Biocon Biologics' New mAbs Facility in India and Renews GMP Certifications for India and Malaysia Sites